Back to Search
Start Over
Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study
- Source :
- Clinical Infectious Diseases. 62:S161-S167
- Publication Year :
- 2016
- Publisher :
- Oxford University Press (OUP), 2016.
-
Abstract
- BACKGROUND Botswana introduced monovalent G1P rotavirus vaccine (RV1) in July 2012, providing one of the first opportunities to assess the effectiveness of routine RV1 vaccination in a high-burden setting in Africa. We sought to determine the effectiveness of RV1 against rotavirus diarrhea hospitalization using a case-control evaluation. METHODS Vaccine age-eligible children
- Subjects :
- Diarrhea
Male
Rotavirus
Microbiology (medical)
Pediatrics
medicine.medical_specialty
Genotype
030231 tropical medicine
Vaccines, Attenuated
urologic and male genital diseases
medicine.disease_cause
Rotavirus Infections
Feces
03 medical and health sciences
0302 clinical medicine
Humans
Medicine
Prospective Studies
030212 general & internal medicine
Vaccine Potency
Botswana
business.industry
Malnutrition
Birth Month
Rotavirus Vaccines
Case-control study
Infant
medicine.disease
Rotavirus vaccine
Confidence interval
Hospitalization
Vaccination
Logistic Models
Infectious Diseases
Case-Control Studies
Child, Preschool
Female
medicine.symptom
business
Subjects
Details
- ISSN :
- 15376591 and 10584838
- Volume :
- 62
- Database :
- OpenAIRE
- Journal :
- Clinical Infectious Diseases
- Accession number :
- edsair.doi.dedup.....4a038aec6b6d33111f59651f78f7d8a9
- Full Text :
- https://doi.org/10.1093/cid/civ1207